QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

20,995 signal articles · 508 in last 24h · 103,318 total before filter · latest 24m ago
508last 24h
2496last 7d
483● bullish (7d)
253● bearish (7d)
197publishers
AllMacro246Earnings1472M&A138Regulatory16Product4Analyst29
✕ clear all filtersticker: ^GSPCsentiment: bullishSentiment:bullishneutralbearishshow all (incl. clickbait)
Moderna Earnings Are Better Than Expected So Why Is the Stock Falling?
Barrons.com5d agobullish
Moderna Earnings Are Better Than Expected So Why Is the Stock Falling?

Moderna posted a narrower per-share loss and higher revenue in its latest quarter, but shares were tumbling anyway. Moderna posted a loss of $1.97 a share, narrower than the loss of $2.01 Wall Street had anticipated, and slimmer than the per-share loss of $2.13 reported last year. The drugmaker reiterated its full-year guidance of 10% revenue growth, evenly split between U.S. and international sales.

Teradyne Stock Jumps as Earnings Guidance Does the Seemingly Impossible—Impresses Wall Street
Barrons.com7d agobullish
Teradyne Stock Jumps as Earnings Guidance Does the Seemingly Impossible—Impresses Wall Street

It takes a lot for artificial-intelligence trade-related companies to impress Wall Street with earnings or guidance these days, but Teradyne has done just that. Shares of the semiconductor test equipment manufacturer rose 9% to $338.43 on Wednesday after the company late Tuesday reported better-than-expected second-quarter earnings and solid quarterly guidance. Teradyne posted adjusted earnings of $2.47 a share in the second quarter, up from 57 cents a year ago and well above Wall Street’s expectation of $2.09.